Behavior Analysis And Learning Solutions, Corp | |
12249 Sw 18th Ter Miami FL 33175-7365 | |
(786) 370-3972 | |
Not Available |
Full Name | Behavior Analysis And Learning Solutions, Corp |
---|---|
Speciality | Behavior Analyst |
Location | 12249 Sw 18th Ter, Miami, Florida |
Authorized Official Name and Position | Amneris Betancourt (PRESIDENT) |
Authorized Official Contact | 7863703972 |
Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
Mailing Address | Practice Location Address |
---|---|
Behavior Analysis And Learning Solutions, Corp 12249 Sw 18th Ter Miami FL 33175-7365 Ph: (786) 370-3972 | Behavior Analysis And Learning Solutions, Corp 12249 Sw 18th Ter Miami FL 33175-7365 Ph: (786) 370-3972 |
NPI Number | 1043928518 |
---|---|
Provider Enumeration Date | 11/14/2022 |
Last Update Date | 11/14/2022 |
Certification Date | 11/14/2022 |
Identifier | Type | State | Issuer |
---|---|---|---|
1043928518 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103K00000X | Behavior Analyst | (* (Not Available)) | Primary |
News Archive
Allergan plc, a leading global pharmaceutical company, announced today that new data on the investigational medication rapastinel (GLYX-13) and its lack of impairment on cognitive function were published in the peer-reviewed journal Behavioural Brain Research.
Modern anticancer therapies aim to attack tumor cells while sparing healthy tissue. An interdisciplinary team of researchers at Helmholtz-Zentrum Dresden-Rossendorf and FU Berlin has made important progress in this area: the scientists have produced tiny nanoparticles that are designed to specifically target cancer cells.
Loxo Oncology, Inc., a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers, today announced new results from its Phase 1 open-label, dose-escalation trial of LOXO-101, a selective inhibitor of tropomyosin receptor kinase (TRK) signaling molecules, and the first preclinical data for its RET and FGFR programs. The data are being presented at the 2015 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston.
Latest research examining the potential hazards of a high calcium intake finds an increased mortality risk among women with a high intake through diet and supplements.
Researchers at Moffitt Cancer Center, the University of South Florida and the International Agency for Research on Cancer in France have studied the patterns and timing of sunlight exposure and how each is related to two nonmelanoma skin cancers - basal cell carcinoma and squamous cell carcinoma.
› Verified 3 days ago
Future Care Solution Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 3911 Sw 67th Ave, Miami, FL 33155 Phone: 305-740-6960 Fax: 305-740-6959 | |
Kids Behaviors Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 14554 Sw 143rd Pl, Miami, FL 33186 Phone: 786-523-2414 | |
Deborah M. Thevenin, Ph.d., Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 7685 Sw 104th St, Suite 100, Miami, FL 33156 Phone: 305-666-8000 Fax: 305-666-4311 | |
Miami-dade County Community Action And Human Services Department Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 150 Nw 79th St, Miami, FL 33150 Phone: 305-751-4342 Fax: 305-759-2763 | |
Luzmila Victorero Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 43 Sw 77th Ave, Miami, FL 33144 Phone: 786-406-4933 | |
Adaga Therapy Group Corp Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2926 Sw 145th Ave, Miami, FL 33175 Phone: 305-301-1856 | |
Advance Behavior Coalition Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 14531 Sw 157th Ct, Miami, FL 33196 Phone: 305-733-9005 |